From The Charleston Gazette-Mail
MORGANTOWN, W.Va. — Mylan, the generic pharmaceutical company that was founded in West Virginia and remains one of the state’s largest private employers, will be combined next year with a spinoff company from Pfizer, the nation’s largest drugmaker.
The new company, which has not been named, will combine Mylan’s generic drug business with Pfizer’s Upjohn, which sells one-time blockbuster drugs like Viagra, Lipitor, Xanax and Zoloft that have lost patent protection.
The complex deal, expected to close in the middle of next year, will create a company with estimated 2020 revenue in excess of $19 billion, with sales in more than 165 countries. …